Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2007
08/16/2007WO2007064844A3 Anti-viral griffithsin compounds, compositions, and methods of use
08/16/2007WO2007060440A3 The use of peptides in anti-ulcer therapy
08/16/2007WO2007054911A3 Compositions useful for recovering original trophism and pigmentation, and for stimulating growth of the integumentary apparatus, uses and products thereof .
08/16/2007WO2007053446A3 Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species
08/16/2007WO2007047969A3 Methods of decreasing vascular calcification using il-1 inhibitors
08/16/2007WO2007029003A3 Method of preparing a hydrogel
08/16/2007WO2007019573A3 Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
08/16/2007WO2007014391B1 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
08/16/2007WO2006055959A3 Pf4 pharmacophores and their uses
08/16/2007WO2006052134A3 Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
08/16/2007WO2006047728A3 Bmp gene and fusion protein
08/16/2007WO2006026020A3 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
08/16/2007WO2006023781A3 Neublastin variants
08/16/2007WO2006020841A3 Apparatus and method for transdermal delivery of natriuretic peptides
08/16/2007WO2005012489A3 Targeting endothelium for tissue-specific delivery of agents
08/16/2007WO2004091609A3 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
08/16/2007WO2004071461A3 Tra16 a tr4/tr2 repressor
08/16/2007WO2004064763A3 Cleavage of serum response factor in cardiac diagnosis and therapy
08/16/2007WO2004041778A3 A method for increasing synaptic growth or plasticity
08/16/2007WO2004000997A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/16/2007WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/16/2007WO2003022226A3 Neurotrophic components of the adnf i complex
08/16/2007WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
08/16/2007US20070191592 amidated peptide; stress-related conditions
08/16/2007US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity
08/16/2007US20070191310 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; 1-Stearoyl-2-{3-[2-(2,6-dichloroanilino)phenylacetamido]propanoyl}-sn-glycero-3-phosphocholine
08/16/2007US20070191300 selectively modulating NF (Nuclear Factor)- kappa B dependent gene transcription in a cell comprised of modulating I kappa B kinase (IKK) alpha protein activity in the cell
08/16/2007US20070191297 Methods of treating and monitoring systemic lupus erythematosus in individuals
08/16/2007US20070191294 Short interfering rna (sirna) analogues
08/16/2007US20070191284 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents
08/16/2007US20070191283 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
08/16/2007US20070191282 Composition for suppressing re-elevation of cholesterol, and usage thereof
08/16/2007US20070191281 Compound containing a labile disulfide bond
08/16/2007US20070191280 High Purity Lipopeptides
08/16/2007US20070191279 Administering adenosine A1 receptor antagonist 1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine(CVT-124) for modulating osteoclastogenesis and for treating bone diseases characterized by bone loss or a decrease in bone mass or density
08/16/2007US20070191278 Cd8 as an inhibitor of the cellular immune system
08/16/2007US20070191277 Methods for modulating angiogenesis
08/16/2007US20070191276 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
08/16/2007US20070191275 Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
08/16/2007US20070191274 Active hedgehog protein conjugate
08/16/2007US20070191273 Modulation of angiogenesis
08/16/2007US20070191272 Proteinaceous pharmaceuticals and uses thereof
08/16/2007US20070191271 Method for stabilizing polypeptides lacking methionine
08/16/2007US20070191270 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/16/2007US20070191269 Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility
08/16/2007US20070191268 Recombiant lubricin molecules and uses thereof
08/16/2007US20070191267 Use of tyrosine kinase inhibitors for treating cerebral ischemia
08/16/2007US20070191266 Administering cyclosporin A to the eye or eyelid of a human or animal afflicted with, for example, suffering from or having, blepharospasm not resulting from local ocular surface or ocularsurface disease; primary/secondary blepharospasm; Parkinson'sdisease; tartive dystonia
08/16/2007US20070191265 Anti-HIV Agent
08/16/2007US20070191264 Methods for inhibiting the growth of bacteria
08/16/2007US20070191263 Valency platform molecules comprising aminooxy groups
08/16/2007US20070191262 Cancer Therapy and Prevention Based on Modulation of Complement activity
08/16/2007US20070191260 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug containing the derivative
08/16/2007US20070190652 Anti-HIV Agent
08/16/2007US20070190644 With vaccinia virus complement control protein, poxvirus encoded
08/16/2007US20070190612 31 Human Secreted Proteins
08/16/2007US20070190609 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents; atopic allergy, and related disorders
08/16/2007US20070190607 Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function
08/16/2007US20070190581 Density enhanced protein tyrosine phosphatases
08/16/2007US20070190577 Biologically active synthetic thyrotropin and cloned gene for producing same
08/16/2007US20070190576 Mitogenic oxygenase regulators
08/16/2007US20070190575 Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
08/16/2007US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents
08/16/2007US20070190162 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same
08/16/2007US20070190159 Polyamino acid-based insulin preparation
08/16/2007US20070190158 Pharmaceutical compositions in particulate form
08/16/2007US20070190154 Method for the production of emulsion-based micro particles
08/16/2007US20070190152 Method for providing an active agent topically to the skin
08/16/2007US20070190132 Pharmaceutical compositions for oral and topical administration
08/16/2007US20070190130 Protein hydrolysate excipients
08/16/2007US20070190127 Extended release of neuregulin for improved cardiac function
08/16/2007US20070190122 Skin dressings
08/16/2007US20070190114 Antioxidant health lozenges
08/16/2007US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release
08/16/2007US20070190109 biodegradable filament having arranged thereon pressed form bodies consisting of at least one member of group of antibiotic salts such as gentamicin myristate, tobramycin palmitate; for treatment of chronic osteomyelitis
08/16/2007US20070190107 Cell selective implant surface with controlled release of bioactive agents
08/16/2007US20070190101 Flowable bone grafts
08/16/2007US20070190099 Method of Use of Bioactive Materials
08/16/2007US20070190080 Non-aqueous compositions for oral delivery of insoluble bioactive agents
08/16/2007US20070190078 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders
08/16/2007US20070190077 Anti-HIV agents
08/16/2007US20070190064 Enteral composition for the prevention and/or treatment of sepis
08/16/2007US20070190061 Peptides for stimulating an immune response against melanoma
08/16/2007US20070190056 Muscle regeneration compositions and uses therefor
08/16/2007US20070190054 Prevention and treatment of complement-associated disorders
08/16/2007US20070190053 Treament of lupus nephritis with anti-CD40L compounds
08/16/2007US20070190049 Use of A33 antigens and JAM-IT
08/16/2007US20070190045 Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity
08/16/2007US20070190042 Composition for collecting and preserving placental stem cells and methods of using the composition
08/16/2007US20070190041 Novel benzothiazepine and bensothiepine compounds
08/16/2007US20070190040 Recombinant p53 adenovirus methods and compositions
08/16/2007US20070190033 treatment of a bacterial infection characterized by biofilm formation; for Pseudomonas aeruginosa infections such as those in canine ears
08/16/2007US20070190026 Method Of Treatment Using Interferon-Tau
08/16/2007US20070190025 Method to enhance hematopoiesis
08/16/2007US20070190024 Il-11 muteins
08/16/2007US20070190023 Methods and compositions for modulating the mobilization of stem cells
08/16/2007US20070190022 Combination methods of treating cancer
08/16/2007US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
08/16/2007CA2677742A1 Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
08/16/2007CA2649134A1 Synthesis of sialic acid in plants
1 ... 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 ... 3163